Keywords

MedicineEstramustineQuality of life (healthcare)DocetaxelProstate cancerAnxietyCancerInternal medicineClinical trialBrief Pain InventoryPhysical therapyOncologyPsychiatryChronic pain

Affiliated Institutions

Related Publications

Publication Info

Year
2001
Type
article
Volume
12
Issue
5
Pages
633-641
Citations
52
Access
Closed

External Links

Citation Metrics

52
OpenAlex

Cite This

Alice B. Kornblith, James E. Herndon, E Zuckerman et al. (2001). The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study. Annals of Oncology , 12 (5) , 633-641. https://doi.org/10.1023/a:1011102619058

Identifiers

DOI
10.1023/a:1011102619058